Short vs long blood-flow pause during liver cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial compares two different lengths of time (15 vs 45 minutes) that the blood flow to the liver is temporarily stopped during surgery to remove liver tumors. The goal is to see if the shorter time works just as well as the longer one while being safer for the liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a tumor in your liver (either cancer that started there or cancer that has spread there from another organ).
- You are older than 18.
- You are healthy enough to have surgery to remove part of your liver.
- Your daily activities are not significantly limited (WHO score of 2 or less).
- You do not have cirrhosis or severe liver dysfunction.
- You haven't had prior liver surgery or treatments like ablation or chemoembolization for your liver tumors.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a way to help people who need liver surgery but have a very small remaining liver after the operation. It tests a special growth observation approach to see if it can safely increase the size of the future liver remnant.
This trial tests a procedure to lower blood loss during liver transplant for patients with high blood pressure in the liver. It may help those who have had a previous transplant, abdominal surgery, or certain complications of liver disease.
This trial studies whether a technique called the Pringle maneuver (temporarily stopping blood flow to the liver during surgery) affects gallbladder health after liver surgery. It is for people having a liver tumor removed while keeping their gallbladder.
This trial tests a new way to control blood flow during laparoscopic liver surgery. It compares two methods to see which is safer and more effective for patients with certain liver conditions.
This trial tests whether using stroke volume variation (SVV) is better than central venous pressure (CVP) to guide fluid management and reduce bleeding during open liver surgery. It aims to find a safer way to manage fluids during the operation.
This trial looks at a special two-step surgery called ALPPS for people with liver cancer that can't be removed in one operation. The first step helps the liver grow more healthy tissue, and then the second step removes the tumor. The goal is to understand how well this works and how the liver regenerates.
Hear when a new Liver Cancer, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.